
Evaluatepharma
EvaluatePharma provides pharma commercial intelligence, news, and analysis. Their core products include forecasting tools like Evaluate Pharma, Evaluate Omnium, and Evaluate Epi, alongside competitive intelligence platforms and data solutions such as Biomedtracker and Datamonitor Healthcare.
About
EvaluatePharma provides pharma commercial intelligence, news, and analysis. Their core products include forecasting tools like Evaluate Pharma, Evaluate Omnium, and Evaluate Epi, alongside competitive intelligence platforms and data solutions such as Biomedtracker and Datamonitor Healthcare. They serve organizations in the biopharma and financial services sectors, empowering them with data-driven insights for decision-making, commercial strategy, business development, portfolio optimization, and competitive analysis.
Key facts
- Website
- evaluate.com
- Founded
- 2026
- Employees
- 120
Tech stack
Detected on evaluate.com, last scanned 29 Oct 2026. Run your own scan
- Frontend
- jQuery
- Analytics
- Google Analytics 4, Google Tag Manager
- SEO
- Yoast SEO
- Observability
- FullStory
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Hosting
- AWS
- Email provider
- Mimecast
- Email marketing
- Adobe Marketo, Oracle Eloqua
- Cookie consent
- OneTrust
- Video / media
- Vimeo, YouTube
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is Evaluatepharma trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Evaluatepharma is 69 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How many employees does Evaluatepharma have?
Evaluatepharma has approximately 120 people on record.
A tool we built
Monitor
Watch a company site for pricing, jobs, and leadership changes. Use it when a profile should ping you instead of you rechecking it.
Need it connected to Evaluatepharma or your own stack? Ask for a custom integration. We reply within 2 days.
SEC filings, insider activity, nonprofit links and pay benchmarks for Evaluatepharma:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules


